Company profile: Capacity Bio
1.1 - Company Overview
Company description
- Provider of mitophagy-focused therapeutics and a development platform to restore mitochondrial quality control in disease. Offers mitophagy agonists (small molecules, peptides, nanoparticles) to enhance removal of dysfunctional mitochondria; mitochondrial modulators in preclinical programs for mitochondrial dysfunction across various diseases; and a mitophagy therapeutic platform to induce mitochondrial turnover and improve mitochondrial performance.
Products and services
- Mitophagy Therapeutic Platform: Advanced platform architects therapies that induce mitochondrial turnover, improving mitochondrial quality and performance to restore mitochondrial quality control in disease contexts
- Mitophagy Agonists: Small-molecule class enhances identification and removal of dysfunctional mitochondria, complemented by peptide and nanoparticle assemblies to drive mitophagy and elevate mitochondrial turnover
- Mitochondrial Modulators: Preclinical-stage programs develop treatments for mitochondrial dysfunction across various diseases to restore mitochondrial quality control in disease through modulation of mitochondrial function
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Capacity Bio
Xcenda
HQ: United States
Website
- Description: Provider of strategic consultancy and managed markets agency services delivering strategic insights, health economics and outcomes research (HEOR) expertise, and reimbursement support to global companies and emerging pre-commercialization phase firms, with 20+ years of real-world experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xcenda company profile →
Corgenix
HQ: United States
Website
- Description: Provider of in vitro diagnostic products, including ELISA tests and vascular disease assays (antiphospholipid antibody), engaged in research, development, manufacturing, and marketing in North America and internationally. Offers contract development, GMP/FDA-registered manufacturing, CAP/CLIA lab testing, quality and regulatory (ISO13485, FDA) services, and clinical trial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corgenix company profile →
Legacy Packaging
HQ: United States
Website
- Description: Provider of pharmaceutical packaging services including bottle filling (30cc–1500cc), blister packaging (thermoform and coldform), and unit-of-use bottling under its own or client NDC codes with rebate management. Offers Ecoslide compliance packaging (senior-friendly, child-resistant), secondary packaging (cartoning, clamshell/blistershell filling, display assembly, inspection), and inline/offline serialization solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Legacy Packaging company profile →
Metrion Biosciences
HQ: United Kingdom
Website
- Description: Provider of specialist ion channel contract research for drug discovery to pharmaceutical and bioscience customers worldwide, including validated ion channel screening, CiPA-compliant human cardiac ion channel assays (GLP hERG), neuroscience ion channel and neurotoxicology screening, translational phenotypic assays, integrated ion channel research programs, and HTS for hit finding, lead optimization, and selectivity profiling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metrion Biosciences company profile →
ICON
HQ: Ireland
Website
- Description: Provider of outsourced development services to pharmaceutical, biotechnology, medical device, biosimilar and generic organizations, specializing in strategic development, management and analysis of programs supporting clinical development from compound selection through Phase I-IV clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ICON company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Capacity Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Capacity Bio
2.2 - Growth funds investing in similar companies to Capacity Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Capacity Bio
4.2 - Public trading comparable groups for Capacity Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →